Optive
Optive is a medical device with 13 clinical trials. Historical success rate of 90.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
9 of 12 finished
25.0%
3 ended early
0
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive®
A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye
Ocular Discomfort Assessment After Intravitreal Injections
Tears Substitutions and Their Effects on Higher Order Aberrometery
Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome
Clinical Trials (13)
Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive®
A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye
Ocular Discomfort Assessment After Intravitreal Injections
Tears Substitutions and Their Effects on Higher Order Aberrometery
Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome
Osmoprotective Containing Lubricants in Dysfunctional Tear Syndrome and Post Refractive Surgery Patients
Comparative Efficacy of SYSTANE® ULTRA vs Optive™ in Improving Tear Film Break-up Time
Evaluate Artificial Tear Efficacy in Moderate to Severe Dry Eye
Evaluation of SYSTANE Ultra Lubricant Eye Drops
Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion
Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses
Refractive Surgery and Optive Compatibility Study
A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye
All 13 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 13